Supramolecular "All-in-one" Nanodrug Based on Perylene Diimide for Dual-mode Imagings Guided PTT-chemotherapy
Jiazhen Wu,Nan Wang,Guozheng Liu,Mingming Luan,Mingyang Zhou,Yanjuan Wu
DOI: https://doi.org/10.1039/d4nj00428k
IF: 3.3
2024-05-29
New Journal of Chemistry
Abstract:Combination of photothermal therapy (PTT) and chemotherapy has been extensively investigated as a promising anticancer strategy, which can maximize therapeutic effect, reversal multidrug resistance, and reduce side effect. However, the conventional nanodrug delivery system incorporated photothermal agent and chemotherapeutic drug together shows some disadvantages, including lower drug loading content, complex preparation process, unpredictable safety risks of carrier. Herein, a perylene diimide (PDI) derivative, PDI0, was synthesized as photothermal agent, which could co-assemble with chemotherapeutic drug DOX to developed novel multifunctional supramolecular nanodrugs. The prepared nanodrugs DP1, DP2, and DP3 with ultra-high drugs loading capacity were carefully characterized by UV-Vis absorption spectrum, fluorescence spectrum, DLS, and TEM. Notably, DP2 showed the appropriate average size of ∼73.4 nm. DP2 was sensitive to the external light and internal lysosome acidic pH stimuli, and the photothermal conversion efficiency (η) was ∼54.34%. The photothermal and photoacoustic (PA) dual-model imagings, and anticancer effect were further evaluated by in vitro and in vivo investigations. Therefore, our prepared carrier-free nanodrug DP2 may hold potential applications for dual-mode imagings guided synergistic PTT-chemotherapy.
chemistry, multidisciplinary